2025-09-11 Investor [Summary] Consolidated Financial Results for the Fiscal Year Ended July 31, 2025 (Under Japanese GAAP) 2025-09-08 Investor Notice Regarding Revision of Full-Year Financial Results Forecast for the Fiscal Year Ended July 2025 2025-09-08 Investor Notice Regarding Special Loss (non-consolidated) due to Impairment of Investment in a Subsidiary 2025-09-04 Investor Notice Regarding Execution of Loan Agreement with Financial Covenants 2025-08-19 Investor Notice Regarding Construction of a New Plant by Our Consolidated Subsidiary and Execution of a Loan Agreement with Financial Covenants 2025-07-16 Research and Development Pharma Foods’ Antibody Technology Advances as Takeda Exercises Sequence Purchase Option 2025-06-16 Investor Notice Regarding Construction of a New Plant by Our Consolidated Subsidiary and Execution of a Loan Agreement with Financial Covenants 2025-06-10 Investor Supplementary Materials of Consolidated Financial Results for the Nine Months Ended April 30, 2025 2025-06-10 Investor [Summary]Consolidated Financial Results for the Nine Months Ended April 30, 2025 (Under Japanese GAAP) 2025-05-14 Investor Notice Concerning Results of Acquisition of Own Shares Through Off-Auction Own Share Repurchase Trading System (ToSTNeT-3) More